Ondas Q3 Surge and Improved Break-Even Forecast Challenge the Wait Rating

What happened

Ondas Holdings reported Q3 revenue up 1,558% year-over-year, a step change driven largely by acquisitions including DZYNE, Cyberhawk, and High Point, which the company began consolidating earlier in 2026. Management updated its profitability forecast, now guiding to break-even sooner than previously expected, a notable shift from the $50.6 million adjusted EBITDA loss recorded in Q2. The prior DeepValue report had a WAIT rating, emphasizing that the stock already priced in substantial success and that proof of shipped revenue and narrowing losses was required before turning constructive. This quarter's update appears to address the revenue side of that thesis, but the quality of earnings, cash conversion, and integration of acquired businesses remain key open questions. The market reacted positively to the headline, but investors should scrutinize the components of the surge and the credibility of the break-even timeline.

Implication

The updated profitability forecast reduces one of the key uncertainties that had kept the rating at WAIT, as management now sees a path to break-even sooner than the market expected. However, the previous report highlighted that the balance-sheet cushion and acquisition scale have not yet translated into per-share economic value, and this quarter's revenue jump is likely still largely inorganic. The next critical data points are the cash flow statement and management's commentary on organic growth, gross margin progression, and any new share issuance after the pending DZYNE shares become effective. If Q4 and 2027 guidance show sustained improvement in adjusted EBITDA and free cash flow alongside revenue growth, the thesis could shift to a more constructive stance with a higher attractive entry level. Conversely, if the surge proves to be a one-off ordering spike or integration costs continue to exceed expectations, the stock could retest lower levels despite the headline growth.

Thesis delta

The prior thesis centered on the need to prove conversion of backlog into shipped revenue and narrowing losses before gaining confidence. This quarter's revenue surge and earlier break-even forecast partially satisfy the revenue proof, but the durability and cash-flow quality of that growth remain unverified. The rating is likely to shift from WAIT toward a more constructive stance only if subsequent reports confirm organic contribution and operating leverage; otherwise, the thesis remains WAIT with a tighter focus on execution risk.